AU2001270231A1 - Localized delivery to a target surface - Google Patents

Localized delivery to a target surface

Info

Publication number
AU2001270231A1
AU2001270231A1 AU2001270231A AU7023101A AU2001270231A1 AU 2001270231 A1 AU2001270231 A1 AU 2001270231A1 AU 2001270231 A AU2001270231 A AU 2001270231A AU 7023101 A AU7023101 A AU 7023101A AU 2001270231 A1 AU2001270231 A1 AU 2001270231A1
Authority
AU
Australia
Prior art keywords
target surface
localized delivery
localized
delivery
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270231A
Inventor
Timothy E. Deglau
Flordeliza S. Villanueva
William R. Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Publication of AU2001270231A1 publication Critical patent/AU2001270231A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/66Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
    • A61K47/665Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
AU2001270231A 2000-06-28 2001-06-28 Localized delivery to a target surface Abandoned AU2001270231A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21486500P 2000-06-28 2000-06-28
US60214865 2000-06-28
PCT/US2001/020597 WO2002000685A1 (en) 2000-06-28 2001-06-28 Localized delivery to a target surface

Publications (1)

Publication Number Publication Date
AU2001270231A1 true AU2001270231A1 (en) 2002-01-08

Family

ID=22800707

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270231A Abandoned AU2001270231A1 (en) 2000-06-28 2001-06-28 Localized delivery to a target surface

Country Status (3)

Country Link
US (1) US20020022266A1 (en)
AU (1) AU2001270231A1 (en)
WO (1) WO2002000685A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034643B2 (en) * 2003-09-19 2011-10-11 Tinggi Technologies Private Limited Method for fabrication of a semiconductor device
EP1799278A2 (en) 2004-09-28 2007-06-27 Baylor University Spatially-defined modification of fresh tissue using covalent chemistry
AU2007221051B2 (en) * 2006-02-28 2012-11-08 Covidien Lp Tissue adhesives and sealants and methods for their use
US8835513B2 (en) 2006-02-28 2014-09-16 Covidien Lp Drug delivery devices
US8349349B2 (en) * 2006-02-28 2013-01-08 Covidien Lp Tissue adhesives and sealants and method for their use
US20110206740A1 (en) * 2008-04-29 2011-08-25 Karp Jeffrey M Cell Membrane Engineering
US9161756B2 (en) 2012-03-16 2015-10-20 Covidien Lp Closure tape dispenser
US9572580B2 (en) 2012-03-16 2017-02-21 Covidien Lp Closure tape dispenser
US10814036B2 (en) 2016-11-07 2020-10-27 Baylor University Drug-eluting live tissue for transplantation
US11357542B2 (en) 2019-06-21 2022-06-14 Covidien Lp Valve assembly and retainer for surgical access assembly

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304121A (en) * 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5674192A (en) * 1990-12-28 1997-10-07 Boston Scientific Corporation Drug delivery
US5612034A (en) * 1990-10-03 1997-03-18 Redcell, Inc. Super-globuling for in vivo extended lifetimes
US20020018751A1 (en) * 1993-10-15 2002-02-14 BRIDON Dominique P. Cellular and serum protein anchors for diagnostic imaging
US5478837A (en) * 1994-06-07 1995-12-26 University Of Southern California Use of quinacrine in preventing adhesion formation
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
WO1997009068A2 (en) * 1995-09-01 1997-03-13 University Of Washington Interactive molecular conjugates
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US5977252A (en) * 1996-03-07 1999-11-02 University Of Pittsburgh Covalent modification of surfaces with polymers to increase biocompatibility
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
US6369039B1 (en) * 1998-06-30 2002-04-09 Scimed Life Sytems, Inc. High efficiency local drug delivery

Also Published As

Publication number Publication date
US20020022266A1 (en) 2002-02-21
WO2002000685A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AU2002323044A1 (en) Delivering material to a patient
AU2001290600A1 (en) Bond pattern
AUPQ560400A0 (en) A skateboard
AU2001228773A1 (en) Spray dispenser
AU2001275286A1 (en) Transdermal delivery
AU2001259404A1 (en) Surface modified nozzle plate
AU2001270231A1 (en) Localized delivery to a target surface
AU2002214978A1 (en) Beta-Thio-amino acids
AU2001257250A1 (en) Notched toe panty hose
AUPR000900A0 (en) A berley dispenser
AU3918501A (en) Atomiser
AU2001295777A1 (en) Target
AUPQ948800A0 (en) A vaccine strategy
AU2002211741A1 (en) Surface modifying composition
AU2001269257A1 (en) Target face
AU2001259095A1 (en) A nebulizer
AU2001287962A1 (en) A ball
AU5495301A (en) Reflective surface embossing
AU2130901A (en) A mechanical parking
AUPQ160499A0 (en) A game
AU2002230889A1 (en) Target enzymes
AUPQ163199A0 (en) A nematicide composition
AUPQ885600A0 (en) A nozzle arrangement
AU2002217000A1 (en) Spray can
AU2002222119A1 (en) Dispenser